<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">mimmun</journal-id><journal-title-group><journal-title xml:lang="ru">Медицинская иммунология</journal-title><trans-title-group xml:lang="en"><trans-title>Medical Immunology (Russia)</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1563-0625</issn><issn pub-type="epub">2313-741X</issn><publisher><publisher-name>SPb RAACI</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.15789/1563-0625-2019-2-293-302</article-id><article-id custom-type="elpub" pub-id-type="custom">mimmun-1589</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ОРИГИНАЛЬНЫЕ СТАТЬИ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>ORIGINAL ARTICLES</subject></subj-group></article-categories><title-group><article-title>СВЯЗЬ  HLA ГАПЛОТИПОВ  С РАЗВИТИЕМ ХРОНИЧЕСКОЙ ОБСТРУКТИВНОЙ БОЛЕЗНИ ЛЕГКИХ  В УСЛОВИЯХ КРЕМНИЙОРГАНИЧЕСКОГО ПРОИЗВОДСТВА</article-title><trans-title-group xml:lang="en"><trans-title>ASSOCIATION OF HLA HAPLOTYPES WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE IN CONDITIONS  OF ORGANIC- SILICON MANUFACTURE</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-5899-6352</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Карзакова</surname><given-names>Л. М.</given-names></name><name name-style="western" xml:lang="en"><surname>Karzakova</surname><given-names>L. M.</given-names></name></name-alternatives><bio xml:lang="ru"/><bio xml:lang="en"/><email xlink:type="simple">luizak58@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Мучукова</surname><given-names>О. М.</given-names></name><name name-style="western" xml:lang="en"><surname>Muchukova</surname><given-names>O. M.</given-names></name></name-alternatives><bio xml:lang="ru"/><bio xml:lang="en"/><email xlink:type="simple">olgahealth@yandex.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Борисова</surname><given-names>Л. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Borisova</surname><given-names>L. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>кандидат медицинских наук, заведующий клинико-диагностической лабораторией</p></bio><bio xml:lang="en"/><email xlink:type="simple">lyudmilabor@mail.ru</email><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-2277-9425</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Кудряшов</surname><given-names>С. И.</given-names></name><name name-style="western" xml:lang="en"><surname>Kudryashov</surname><given-names>S. I.</given-names></name></name-alternatives><bio xml:lang="ru"><p>ассистент кафедры внутренних болезней с курсом клинической иммунологии</p></bio><bio xml:lang="en"/><email xlink:type="simple">medicpro21@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>ФГБОУ ВО "Чувашский государственный университет имени И.Н.Ульянова"</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Chuvashskiiˋ State University</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>БУ «Республиканский эндокринологический диспансер» Минздрава Чувашии</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Republican сlinical endocrinological clinic</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2019</year></pub-date><pub-date pub-type="epub"><day>28</day><month>02</month><year>2019</year></pub-date><volume>21</volume><issue>2</issue><fpage>293</fpage><lpage>302</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Карзакова Л.М., Мучукова О.М., Борисова Л.В., Кудряшов С.И., 2019</copyright-statement><copyright-year>2019</copyright-year><copyright-holder xml:lang="ru">Карзакова Л.М., Мучукова О.М., Борисова Л.В., Кудряшов С.И.</copyright-holder><copyright-holder xml:lang="en">Karzakova L.M., Muchukova O.M., Borisova L.V., Kudryashov S.I.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.mimmun.ru/mimmun/article/view/2019-21-2-10">https://www.mimmun.ru/mimmun/article/view/2019-21-2-10</self-uri><abstract><p>Одной из актуальных проблем современной медицины является поиск генетических маркеров хронической обструктивной болезни легких (ХОБЛ).  В этой связи целью настоящего исследования явилось изучение связи HLA гаплотипов  с ХОБЛ у лиц, заболевание которых развилось в процессе профессиональной деятельности в цехе кремнийорганического производства  ПАО «Химпром» (г. Новочебоксарск, Россия). В исследование включены больные ХОБЛ в стадии ремиссии, принадлежащие чувашской этнической группе России  – 36 женщин и 26 мужчин (средний возраст – 45,4±2,3 года).  Стаж работы составил в среднем 15,2±2,4 года, продолжительность ХОБЛ – 12,3±2,4 года. Курящие составляли 22,0±5,8% от общего числа больных. Группой сравнения служила когорта  здоровых работников кремнийорганического производства.  Типирование HLA-антигенов класса I проводили в стандартном микролимфоцитотоксическом тесте с использованием гистотипирующих анти-HLA-сывороток к 8 антигенам HLA-A  локуса (А1, А2, А3, А9, А10, А11, А19, А28) и 18 антигенам HLA-В локуса (В5, В7, В8, В12, В13, В14, В15, В16, В17, В18, В21, В22, В27, В35, В40, В41, В42, В53) (ЗАО «Межрегиональный центр иммуногенетики и гистотипирующих реагентов «Гисанс», С.-Петербург). HLA-генотипирование аллелей класса II проводили методом мультипраймерной полимеразной цепной реакции (ПЦР) в ДНК, полученной из ядерных клеток периферической крови, с использованием наборов реагентов НПФ «ДНК-Технология» (Москва),  по методике производителя реагентов.  Типировали по 14 аллелям локуса DRB1, 8 аллелям DQA1 и 11 аллелям DQB1. Частоты двухлокусных гаплотипов рассчитывали с использованием компьютерной программы «Arlequin v. 3.01». Силу ассоциации HLA с ХОБЛ определяли с помощью величины относительного риска (ОР) по  формуле J. Haldane.  Статистическую достоверность отличия ОР от 1 определяли по точному двустороннему критерию Фишера.  В результате проведенного исследования установлена положительная  ассоциация  ХОБЛ с гаплотипами: HLA-А9-DQA1*0501, А10-DQA1*0103, А28-DQA1*0102, B7-DQA1*0103. Данные гаплотипы можно отнести к генетическим маркерам предрасположенности к развитию ХОБЛ. Отрицательная ассоциация с заболеванием установлена для гаплотипических сочетаний аллелей HLA-А2-В8,  А19-DQB1*0502-04, B12-DQB1*0502-04, B27-DQA1*0103,  DRB1*01-DQA1*0101, DRB1*07-DQA1*0201, DRB1*13-DQA1*0102.  Данный ряд гаплотипов можно отнести к разряду протективных генетических маркеров  ХОБЛ в условиях  кремнийорганического производства. Результаты проведенного исследования свидетельствуют об ассоциации  ХОБЛ с рядом определенных HLA-гаплотипов.</p><p> </p></abstract><trans-abstract xml:lang="en"><p>One of the urgent problems of modern medicine is the search for genetic markers of chronic obstructive pulmonary disease (COPD).The aim of the study was to investigate the relationship between HLA haplotypes and COPD in individuals whose illness developed during the professional work in the workshop of organic-silicon production of PJSC "Khimprom" (Novocheboksarsk, Russia).The study included patients with COPD in remission, belonging to the Chuvash ethnic group of Russia - 36 women and 26 men (mean age 45.4±2.3 years). The work experience averaged 15.2±2.4 years, the duration of COPD - 12.3±2.4 years. Smokers made up 22.0±5.8% of the total number of patients. The comparison group was a group of non-patients with COPD workers of organic-silicon manufacture. This group was positioned as "stable" to the development of  COPD. Class I HLA antigens were typed in the standard microlymphocytotoxic test using histotyping anti-HLA sera to 8 HLA-A antigens of the locus A1, A2, A3, A9, A10, A11, A19, A28 and  to 18 HLA-B antigens of  the locus  В5, В7, В8, В12, В13, В14, В15, В16, В17, В18, В21, В22, В27, В35, В40, В41, В42, В53) (CJSC “Interregional Center of Immunogenetics and Histotyping Reagents “Gisans”, St. Petersburg). HLA genotyping of class II alleles was carried out by the multi-primer polymerase chain reaction method in DNA, obtained from nuclear cells of peripheral blood, using reagent sets of the firm “DNA-Technology” (Moscow), according to the reagent manufacturer's method. They were typified by 14 alleles of the DRB1 locus, 8 to the DQA1 alleles and 11 to the DQB1 alleles. The frequencies of two-locus haplotypes were calculated using the computer program "Arlequin v. 3.01 ". The association strength of HLA with COPD was determined by the relative risk (RR) of the formula J. Haldane. The statistical reliability of the difference between RR and 1 was determined by the exact two-sided Fisher test. As a result of the study, the positive association of COPD with haplotypes was established: HLA-A9-DQA1*0501,  A10-DQA1*0103, A28-DQA1*0102,  B7-DQA1* 0103. These haplotypes can be attributed to genetic markers of predisposition to the development of COPD. The negative association with the disease was established for haplotypic combinations of the alleles HLA-A2-B8, A19-DQB1*0502-04, B12-DQB1*0502-04, B27-DQA1*0103, DRB1*01-DQA1*0101, DRB1*07-DQA1*0201, DRB1*13-DQA1 * 0102. This series of haplotypes can be attributed to the category of protective genetic markers of COPD in conditions of organic-silicon manufacture. In continuation of our studies, further research is needed to identify "marker" HLA haplotypes in COPD in other ethnic populations, as well as under the influence of other aggressive air pollutants. The results of the study indicate the association of COPD with a number of specific HLA-haplotypes.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>HLA гаплотипы</kwd><kwd>хроническая обструктивная  болезнь легких</kwd></kwd-group><kwd-group xml:lang="en"><kwd>HLA haplotypes</kwd><kwd>chronic obstructive pulmonary disease</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Алексеев Л.П., Дедов И.И., Зилов А.В., Болдырева М.Н., Демидова И.Ю., Трофимов Д.Ю., Хаитов Р.М. Межпопуляционный подход в установлении ассоциированной с HLA генетической предрасположенности к инсулинзависимому сахарному диабету // Сахарный диабет, 1998. № 1. С. 19-21. [Alekseev L.P., Dedov I.I., Zilov A.V., Boldyreva M.N., Demidova I.Yu., Trofimov D.Yu., Khaitov R.M. An interpopulation approach to establishing of HLA-associated genetic predisposition to insulin-dependent diabetes mellitus. Sakharniy diabet = Diabetes Mellitus, 1998, no. 1. pp. 19-21. (In Russ.)]</mixed-citation><mixed-citation xml:lang="en">Алексеев Л.П., Дедов И.И., Зилов А.В., Болдырева М.Н., Демидова И.Ю., Трофимов Д.Ю., Хаитов Р.М. Межпопуляционный подход в установлении ассоциированной с HLA генетической предрасположенности к инсулинзависимому сахарному диабету // Сахарный диабет, 1998. № 1. С. 19-21. [Alekseev L.P., Dedov I.I., Zilov A.V., Boldyreva M.N., Demidova I.Yu., Trofimov D.Yu., Khaitov R.M. An interpopulation approach to establishing of HLA-associated genetic predisposition to insulin-dependent diabetes mellitus. Sakharniy diabet = Diabetes Mellitus, 1998, no. 1. pp. 19-21. (In Russ.)]</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Брыляева Е.В., Крюков Н.Н., Жестков А.В. Иммуногенетические исследования хронической обструктивной болезни легких // Практическая медицина, 2011. Т. 51, № 3. С. 55-57. [Brylyaeva E.V., Kryukov N.N., Zhestkov A.V. Immunogenetic studies of chronic obstructive pulmonary disease. Prakticheskaya meditsina = Practical Medicine, 2011, Vol. 51, no. 3, pp. 55-57. (In Russ.)]</mixed-citation><mixed-citation xml:lang="en">Брыляева Е.В., Крюков Н.Н., Жестков А.В. Иммуногенетические исследования хронической обструктивной болезни легких // Практическая медицина, 2011. Т. 51, № 3. С. 55-57. [Brylyaeva E.V., Kryukov N.N., Zhestkov A.V. Immunogenetic studies of chronic obstructive pulmonary disease. Prakticheskaya meditsina = Practical Medicine, 2011, Vol. 51, no. 3, pp. 55-57. (In Russ.)]</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Зарецкая Ю.М. Клиническая иммуногенетика. М.: Медицина, 1983. 208 с. [Zaretskaya Yu.M. Clinical immunogenetics. Мoscow: Medicine, 1983. 208 p.</mixed-citation><mixed-citation xml:lang="en">Зарецкая Ю.М. Клиническая иммуногенетика. М.: Медицина, 1983. 208 с. [Zaretskaya Yu.M. Clinical immunogenetics. Мoscow: Medicine, 1983. 208 p.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Карзакова Л.М., Мучукова О.М., Борисова Л.В., Кудряшов С.И. Исследование HLA-ассоциаций хронической обструктивной болезни легких в условиях кремнийорганического производства // Клиническая лабораторная диагностика, 2017. Т. 1, № 62. С. 44-49. [Karzakova L.M., Muchukova O.M., Borisova L.V., Kudriashov S.I. The study of HLA associations of chronic obstructive disease of lungs in conditions of organicsilicon manufacture. Klinicheskaya laboratornaya diagnostika = Russian Clinical Laboratory Diagnostics, 2017, Vol. 1, no. 62, pp. 44-49. (In Russ.)]</mixed-citation><mixed-citation xml:lang="en">Карзакова Л.М., Мучукова О.М., Борисова Л.В., Кудряшов С.И. Исследование HLA-ассоциаций хронической обструктивной болезни легких в условиях кремнийорганического производства // Клиническая лабораторная диагностика, 2017. Т. 1, № 62. С. 44-49. [Karzakova L.M., Muchukova O.M., Borisova L.V., Kudriashov S.I. The study of HLA associations of chronic obstructive disease of lungs in conditions of organicsilicon manufacture. Klinicheskaya laboratornaya diagnostika = Russian Clinical Laboratory Diagnostics, 2017, Vol. 1, no. 62, pp. 44-49. (In Russ.)]</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Певницкий Л.А. Статистическая оценка ассоциаций HLA-антигенов с заболеваниями // Вестник АМН СССР, 1988. № 7. C. 48-51. [Pevnitsky L.A. Statistical evaluation of HLA antigens associations with diseases. Vestnik Akademii meditsinskikh nauk SSSR = Bulletin of the Academy of Medical Sciences of the USSR, 1988, no. 7, pp. 48-51. (In Russ.)]</mixed-citation><mixed-citation xml:lang="en">Певницкий Л.А. Статистическая оценка ассоциаций HLA-антигенов с заболеваниями // Вестник АМН СССР, 1988. № 7. C. 48-51. [Pevnitsky L.A. Statistical evaluation of HLA antigens associations with diseases. Vestnik Akademii meditsinskikh nauk SSSR = Bulletin of the Academy of Medical Sciences of the USSR, 1988, no. 7, pp. 48-51. (In Russ.)]</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Сусликов В.Л., Шевницына О.Ю., Козлов В.А. Изучение влияния химических веществ, используемых в производстве кремнийорганических соединений, на состояние работающих // Российский медицинский журнал, 2003. № 6. С. 30-31. [Suslikov V.L., Shevnitsyna O.Yu., Kozlov V.A. Adverse effects produced by chemical substances at the organic-silicon production facilities on the health conditions of workers. Rossiyskiy meditsinskiy zhurnal = Medical Journal of the Russian Federation, 2003, no. 6, pp. 30-31. (In Russ.)]</mixed-citation><mixed-citation xml:lang="en">Сусликов В.Л., Шевницына О.Ю., Козлов В.А. Изучение влияния химических веществ, используемых в производстве кремнийорганических соединений, на состояние работающих // Российский медицинский журнал, 2003. № 6. С. 30-31. [Suslikov V.L., Shevnitsyna O.Yu., Kozlov V.A. Adverse effects produced by chemical substances at the organic-silicon production facilities on the health conditions of workers. Rossiyskiy meditsinskiy zhurnal = Medical Journal of the Russian Federation, 2003, no. 6, pp. 30-31. (In Russ.)]</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Bashir А., Shah N.N., Hazari Y.M., Habib M., Bashir S., Hilal N., Banday M., Asrafuzzaman S., Fazili K.M. Novel variants of SERPIN1A gene: Interplay between alpha1-antitrypsin deficiency and chronic obstructive pulmonary disease. Respir. Med., 2016, Vol. 117, pp. 139-149.</mixed-citation><mixed-citation xml:lang="en">Bashir А., Shah N.N., Hazari Y.M., Habib M., Bashir S., Hilal N., Banday M., Asrafuzzaman S., Fazili K.M. Novel variants of SERPIN1A gene: Interplay between alpha1-antitrypsin deficiency and chronic obstructive pulmonary disease. Respir. Med., 2016, Vol. 117, pp. 139-149.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Begovich A.B., Moonsamy P.V., Mack S.J., Barcellos L.F., Steiner L.L., Grams S., Suraj-Baker V., Hollenbach J., Trachtenberg E., Louie L., Zimmerman P., Hill A.V., Stoneking M., Sasazuki T., Konenkov V.I., Sartakova M.L., Titanji V.P., Rickards O., Klitz W. Genetic variability and linkage disequilibrium within the HLA-DP region: analysis of 15 different populations. Tissue Antigens, 2001, Vol. 57, no. 5, pp. 424-439.</mixed-citation><mixed-citation xml:lang="en">Begovich A.B., Moonsamy P.V., Mack S.J., Barcellos L.F., Steiner L.L., Grams S., Suraj-Baker V., Hollenbach J., Trachtenberg E., Louie L., Zimmerman P., Hill A.V., Stoneking M., Sasazuki T., Konenkov V.I., Sartakova M.L., Titanji V.P., Rickards O., Klitz W. Genetic variability and linkage disequilibrium within the HLA-DP region: analysis of 15 different populations. Tissue Antigens, 2001, Vol. 57, no. 5, pp. 424-439.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Bird Y., Staines-Orozco H. Pulmonary effects of active smoking and secondhand smoke exposure among adolescent students in Juárez, Mexico. Int. J. Chron. Obstruct. Pulmon. Dis., 2016, Vol. 11, pp. 1459-1467.</mixed-citation><mixed-citation xml:lang="en">Bird Y., Staines-Orozco H. Pulmonary effects of active smoking and secondhand smoke exposure among adolescent students in Juárez, Mexico. Int. J. Chron. Obstruct. Pulmon. Dis., 2016, Vol. 11, pp. 1459-1467.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Bodmer W.F., Bodmer J.G. Evolution and function of the HLA system. Brit. Med. Bull. 1978, Vol. 34, no. 3, p. 309.</mixed-citation><mixed-citation xml:lang="en">Bodmer W.F., Bodmer J.G. Evolution and function of the HLA system. Brit. Med. Bull. 1978, Vol. 34, no. 3, p. 309.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Dorak M.T. Statistical analysis in HLA and disease association studies. Available at: http://www.dorak.info/hla/stat.html. Last updated 27 July 2009, last visited at 9 March 2018.</mixed-citation><mixed-citation xml:lang="en">Dorak M.T. Statistical analysis in HLA and disease association studies. Available at: http://www.dorak.info/hla/stat.html. Last updated 27 July 2009, last visited at 9 March 2018.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Hawari F.I., Obeidat N.A., Ghonimat I.M., Ayub H.S., Dawahreh S.S. The effect of habitual waterpipe tobacco smoking on pulmonary function and exercise capacity in young healthy males: A pilot study. Respir. Med., 2017, Vol. 122, pp. 71-75.</mixed-citation><mixed-citation xml:lang="en">Hawari F.I., Obeidat N.A., Ghonimat I.M., Ayub H.S., Dawahreh S.S. The effect of habitual waterpipe tobacco smoking on pulmonary function and exercise capacity in young healthy males: A pilot study. Respir. Med., 2017, Vol. 122, pp. 71-75.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Ikegami H., Kawabata Y., Noso S., Fujisawa T., Ogihara T. Genetics of type 1 diabetes in Asian and Caucasian populations. Diab. Res. Clin. Pract., 2007, Vol. 77, Suppl. 1, pp. 116-121.</mixed-citation><mixed-citation xml:lang="en">Ikegami H., Kawabata Y., Noso S., Fujisawa T., Ogihara T. Genetics of type 1 diabetes in Asian and Caucasian populations. Diab. Res. Clin. Pract., 2007, Vol. 77, Suppl. 1, pp. 116-121.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">McLean S., Barbour V., Wild S., Simpson C., Sheikh A. Models for estimating projections for disease prevalence and burden: a systematic review focusing on chronic obstructive pulmonary disease. J. Health Serv. Res. Policy, 2015, Vol. 20, no. 4, pp. 246-253.</mixed-citation><mixed-citation xml:lang="en">McLean S., Barbour V., Wild S., Simpson C., Sheikh A. Models for estimating projections for disease prevalence and burden: a systematic review focusing on chronic obstructive pulmonary disease. J. Health Serv. Res. Policy, 2015, Vol. 20, no. 4, pp. 246-253.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Słomiński J.M., Kedziora K. Is COPD an autoimmune disease caused by smoking? Przegl. Lek., 2006, Vol. 63, no. 10, pp. 1138-1139.</mixed-citation><mixed-citation xml:lang="en">Słomiński J.M., Kedziora K. Is COPD an autoimmune disease caused by smoking? Przegl. Lek., 2006, Vol. 63, no. 10, pp. 1138-1139.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Soriano J.B., Ancochea J., Miravitlles M., García-Río F., Duran-Tauleria E., Muñoz L., Jiménez-Ruiz C.A., Masa J.F., Viejo J.L., Villasante C., Fernández-Fau L., Sánchez G., Sobradillo-Peña V. Recent trends in COPD prevalence in Spain: a repeated cross-sectional survey 1997-2007. Eur. Respir. J., 2010, Vol. 36, no. 4, pp. 758-765.</mixed-citation><mixed-citation xml:lang="en">Soriano J.B., Ancochea J., Miravitlles M., García-Río F., Duran-Tauleria E., Muñoz L., Jiménez-Ruiz C.A., Masa J.F., Viejo J.L., Villasante C., Fernández-Fau L., Sánchez G., Sobradillo-Peña V. Recent trends in COPD prevalence in Spain: a repeated cross-sectional survey 1997-2007. Eur. Respir. J., 2010, Vol. 36, no. 4, pp. 758-765.</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Vogelmeier C.F., Criner G.J., Martinez F.J. Anzueto A., Barnes P.J., Bourbeau J., Celli B.R., Chen R., Decramer M., Fabbri L.M., Frith P., Halpin D.M., López Varela M.V., Nishimura M., Roche N., Rodriguez-Roisin R., Sin D.D., Singh D., Stockley R., Vestbo J., Wedzicha J.A., Agustí A. Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease 2017 report. GOLD Executive Summary. Am. J. Respir. Crit. Care Med., 2017, Vol. 195, no. 5, pp. 557-582.</mixed-citation><mixed-citation xml:lang="en">Vogelmeier C.F., Criner G.J., Martinez F.J. Anzueto A., Barnes P.J., Bourbeau J., Celli B.R., Chen R., Decramer M., Fabbri L.M., Frith P., Halpin D.M., López Varela M.V., Nishimura M., Roche N., Rodriguez-Roisin R., Sin D.D., Singh D., Stockley R., Vestbo J., Wedzicha J.A., Agustí A. Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease 2017 report. GOLD Executive Summary. Am. J. Respir. Crit. Care Med., 2017, Vol. 195, no. 5, pp. 557-582.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
